main products:Acarbose,Ambroxol Hydrochloride,Benserazide Hydrochloride,Bromhexine Hydrochloride,Colistimethate Sodium,Entecavir Monohydrate,Levodopa,Marbofloxacin,Palonosetron Hydrochloride,Tenofovir Disoproxil Fumarate,Tulathromycin,Piroxicam Beta-cyclodextrin

Shandong Longnuo Pharmaceutical Co., Ltd. was established in May 2012. It is a wholly-owned subsidiary of Shandong Bainuo Pharmaceutical Co., Ltd. It is located in the Qihe River, Shandong Province, which is known as the 'Pearl of the Yellow River

Ruiwei Biotechnology is a biotechnology service company specializing in biomedical technology services, technical consulting and product development. It is committed to the technical development and technical consulting of biotechnology and pharmaceutical technology; as well as the research and development and sales of pharmaceutical intermediates, chemical products and chemical raw materials (excluding hazardous chemicals).

R&D, production and sales of pharmaceutical intermediates. The main reaction types are halogenation, addition, chlorination, esterification and other reactions at room temperature and pressure. We undertake 2-3 step OEM and large-scale production process optimization services.

DKM Chinese official website, small molecules, inhibitors, activators, active compounds.

JNUTRITION Largo Orbassano 68 Turin, leading online supplement store with the best brands and the best prices.

Jiangsu Dena Chemical Co., Ltd. is a Hong Kong-funded enterprise. It currently wholly owns three major production enterprises in the mainland, namely Jiangsu Tianyin Chemical Co., Ltd., Dena (Nanjing) Chemical Co., Ltd., and Dena Chemical Binhai Co., Ltd., and owns two trading companies, Jiangsu Tianyin Chemical Shanghai Co., Ltd. and Tianyin Chemical Industry and Trade (Tianjin) Co., Ltd.

Taizhou Kairui Biotechnology Co., Ltd. is a high-tech limited liability company dedicated to the research and development, production, and sales of high-end pharmaceutical products, closely following the latest newly listed drugs, and focusing on small molecule inhibitor products. The company has synthesis laboratories, analytical laboratories, salt formation and crystal form laboratories, etc.

Founded in 2003, Levitra Pharmaceuticals is a technology-driven innovative pharmaceutical research and development and manufacturing service (CDMO) company. Its main services cover the entire pharmaceutical service process (CMC) of small molecule innovative drugs from laboratory to commercialization, including: process research, pilot production and commercial production services for APIs, registered starting materials and pharmaceutical intermediates from preclinical to market, as well as approval services during the development process.

To provide customers with seamless one-stop service for the research and production of raw materials and intermediates from gram level to kilogram level.